AnalystsPaul Jeng
Paul Jeng's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 31%
#1623 out of 5256 analysts
Average Return
+34.64%
Win Rate
78%7 out of 9
Risk vs Reward
Poor
Good

Paul Jeng's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Context Therapeutics IncCNTX
+126.00%$1.00$2.26
2025-09-17 -
2026-04-20
Strong Buy
Adagene IncADAG
+104.74%$1.90$3.89
2025-11-23 -
2026-04-20
Strong Buy
Immatics NvIMTX
+70.20%$6.61$11.25
2025-09-17 -
2026-04-20
Strong Buy
Ideaya Biosciences IncIDYA
+28.15%$26.22$33.60
2025-09-17 -
2026-04-20
Strong Buy
Immatics NvIMTX
+9.01%$10.32$11.25
2025-11-17 -
2026-04-20
Strong Buy

Paul Jeng Analyst Color

Get additional color on Paul Jeng's coverage of popular stocks

Paul Jeng's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ideaya Biosciences IncIDYA
3Strong Buy$54.00+60.71%Maintains
7 days ago
Adagene IncADAG
2Strong Buy$10.00+157.07%Maintains
15 days ago
Context Therapeutics IncCNTX
2Strong Buy$5.00+121.24%Reiterates
a month ago
Immatics NvIMTX
2Strong Buy$19.00+68.89%Maintains
5 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.